MID1 Antibody (C-term) Blocking peptide

The synthetic peptide sequence used to generate the antibody was selected from the C-term region of MID1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

[E3 ubiquitin-protein ligase Midline-1; E3 ubiquitin-protein ligase Midline-1; E3 ubiquitin-protein ligase Midline-1; midline 1; Midin; Putative transcription factor XPRF; RING finger protein 59; RING finger protein Midline-1; Tripartite motif-containing protein 18]